Aurinia Pharmaceuticals Profit Margin

Aurinia Pharmaceuticals (AUPH) currently reports a profit margin of 100.84% as of June 2026. That compares with 24.47% in the prior-year period — up 312.2% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Aurinia Pharmaceuticals's profit margin history and peer comparisons.

Aurinia Pharmaceuticals's profit margin increased from 24.47% to 100.84% — a 312.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aurinia Pharmaceuticals's profit margin of 100.84% is higher than the Healthcare sector average of 13.89%. That is roughly 625.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Aurinia Pharmaceuticals's current 100.84% should be judged against Healthcare norms (sector average: 13.89%) and against AUPH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 100.84%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Aurinia Pharmaceuticals, and consider following AUPH for alerts when major investors trade the stock.